PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS
石棉诱发的间质肿瘤的发病机制
基本信息
- 批准号:3251307
- 负责人:
- 金额:$ 22.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-06-15 至 1993-07-31
- 项目状态:已结题
- 来源:
- 关键词:asbestos cellular immunity chemical related neoplasm /cancer disease /disorder model electron microscopy environment related neoplasm /cancer fluorescence spectrometry histochemistry /cytochemistry immunofluorescence technique laboratory mouse lymph nodes macrophage macrophage activating factor mesothelioma model design /development neoplasm /cancer immunology northern blottings peritoneum tissue /cell culture
项目摘要
Exposure to asbestos fibers causes mesotheliomas, malignant tumors
arising from the pleural or peritoneal lining, in humans and in
experimental animals. A new model system was developed to induce
mesotheliomas in mice after 30-50 weekly injections of
200 ug of crocidolite asbestos fibers. The proposed experiments
will explore the mechanisms responsible for the development of
these tumors. Two important steps in tumor development are loss
of growth regulation and induction of angiogenesis. Specific poly-
peptide mediators involved in these two critical steps will be
identified in this model system.
It is hypothesized that transforming growth factor (TGF-beta) is
an inhibitor of mesothelial cell proliferation. The effects of
exogenous TGF-beta on proliferation of reactive, preneoplastic.
and neoplastic cell lines will be studied in intro and in vivo.
regulation of mesothelial cell proliferation may occur by a
paracrine or autocrine mechanism. Expression of TGF-beta mRNA by
peritoneal macrophages and mesothelial cells will be determined by
Northern blot analysis and in situ hybridization. TGF-beta is
secreted as a latent, protein-bound complex. Activation of TGF-
beta by macrophages or mesothelial cells exposed to asbestos will
be tested using an in vitro bioassay. In order for neoplastic
mesothelial cells to proliferate autonomously, it is hypothesized
that they escape from inhibition by TGF-beta. The following escape
mechanisms will be explored: physical migration away from
peritoneal macrophages which secrete and activate TGF-beta, loss
of ability to activate endogenous TGF-beta, or decreased response
to active TGF-beta.
Intraperitoneal injection of asbestos fibers induces angiogenesis
in the mesothelial lining after 2 weeks. It is hypothesized that
this early angiogenic response is mediated by angiogenic factors
released from peritoneal macrophages. Expression of mRNA for
angiogenic factors will be determined by Northern blot analysis and
in situ hybridization. Induction of angiogenesis is also a
property of malignant tumors. Release of angiogenic factors from
neoplastic mesothelial cells will be determined using an in vivo
angiogenesis assay.
The role of these mediators in the growth of mesotheliomas in vivo
will be tested using blocking antibodies and specific antagonists.
These experiments may lead to a rational approach to delay or
interrupt the sequence of events leading to the development of
mesotheliomas in individuals exposed to asbestos.
接触石棉纤维会导致间皮瘤,恶性肿瘤
源于人类和人类的胸膜或腹膜衬里
实验动物 开发了一种新的模型系统,
在30-50次每周注射后,
200 μ g青石棉纤维。 拟议的实验
将探讨负责发展
这些肿瘤。 肿瘤发展的两个重要步骤是
生长调节和诱导血管生成。 特异性聚-
参与这两个关键步骤的肽介质将是
在这个模型系统中。
据推测,转化生长因子(TGF-β)
间皮细胞增殖的抑制剂。 的影响
外源性TGF-β对反应性癌前病变增殖的影响。
肿瘤细胞系将在体内和体内进行研究。
间皮细胞增殖的调节可能通过
旁分泌或自分泌机制。 TGF-β mRNA的表达
腹膜巨噬细胞和间皮细胞将通过
北方印迹分析和原位杂交。 TGF-β是
作为潜伏的蛋白质结合复合物分泌。 TGF-β的活化
接触石棉的巨噬细胞或间皮细胞将释放β-淀粉样蛋白,
使用体外生物测定进行测试。 为了使肿瘤
间皮细胞自主增殖,这是假设
使它们摆脱了TGF-β的抑制。 下面的逃生
将探讨各种机制:
分泌和激活TGF-β的腹腔巨噬细胞,
激活内源性TGF-β的能力,或降低反应
转化为活跃的TGF-β
腹腔注射石棉纤维诱导血管生成
在两周后的间皮瘤衬里中。 它是假设
这种早期血管生成反应由血管生成因子介导
从腹腔巨噬细胞释放出来 mRNA的表达
通过北方印迹分析测定血管生成因子,
原位杂交 血管生成的诱导也是一种
恶性肿瘤的性质。 血管生成因子的释放
肿瘤性间皮细胞将使用体内
血管生成测定。
这些介质在体内间皮瘤生长中的作用
将使用封闭抗体和特异性拮抗剂进行测试。
这些实验可能会导致一种合理的方法来延迟或
中断导致发展的事件顺序
间皮瘤在个人暴露于石棉。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Agnes B Kane其他文献
Agnes B Kane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Agnes B Kane', 18)}}的其他基金
Chemical, Structural, and Superstructural Determinants of Nanocarbon Toxicity
纳米碳毒性的化学、结构和上层结构决定因素
- 批准号:
7814469 - 财政年份:2009
- 资助金额:
$ 22.93万 - 项目类别:
Chemical, Structural, and Superstructural Determinants of Nanocarbon Toxicity
纳米碳毒性的化学、结构和上层结构决定因素
- 批准号:
7625054 - 财政年份:2007
- 资助金额:
$ 22.93万 - 项目类别:
Chemical, Structural, and Superstructural Determinants of Nanocarbon Toxicity
纳米碳毒性的化学、结构和上层结构决定因素
- 批准号:
7341336 - 财政年份:2007
- 资助金额:
$ 22.93万 - 项目类别:
Chemical, Structural, and Superstructural Determinants of Nanocarbon Toxicity
纳米碳毒性的化学、结构和上层结构决定因素
- 批准号:
7498514 - 财政年份:2007
- 资助金额:
$ 22.93万 - 项目类别:
PLEURAL DOSIMETRY AND BIOMARKERS OF RESPONSE TO FIBERS
胸膜剂量测定和纤维反应的生物标志物
- 批准号:
2154543 - 财政年份:1992
- 资助金额:
$ 22.93万 - 项目类别:
相似海外基金
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10448950 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
Gingival vaccination strategy to induce both humoral and cellular immunity ideal for elderly vaccination
诱导体液和细胞免疫的牙龈疫苗接种策略非常适合老年人疫苗接种
- 批准号:
22K09932 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10508093 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10501418 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10650823 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
- 批准号:
10449406 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10797812 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10662571 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别: